Jun 18, 2020
Global Endometriosis Market and Competitive Landscape to 2024
May 05, 2020
FDA Clears LPCN 1148 IND Application for Phase 2 Cirrhosis Trial
May 04, 2020
Viriom Announces Initiation of Phase 2 Study Investigating Efficacy of Intramuscular Long-Acting Injectable Nanoformulation of VM1500A in HIV-Infected Patients
Apr 17, 2020
U.S. FDA Denies Clarus's Oral Testosterone Ester Citizen Petition
Apr 16, 2020
Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA
Apr 14, 2020
Granata Bio and IBSA Group Announce Strategic Partnership
Mar 04, 2020
Lipocine Announces TLANDO(TM) PDUFA Date of August 28, 2020
Feb 12, 2020
ANI Announces Launch of Sulfamethoxazole and Trimethoprim Oral Suspension USP 200 mg/40 mg per 5 mL
Jan 22, 2020
Theramex Acquires Commercial Rights for Oral Contraceptive Zoely
Dec 17, 2019
Prasco launches NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring) Authorized Generic in the United States
Sep 16, 2019
Exeltis USA, Inc. Announces the Launch of Slynd(TM)(drospirenone) tablets, 4 mg, the First and Only Progestin-Only Pill Providing Pregnancy Prevention with a 24-hour missed pill window and 24/4 Dosing Regimen
Aug 20, 2019
Forendo Pharma Commences Phase 1b Proof of Mechanism Study with its Lead Endometriosis Program, HSD17B1 Inhibitor FOR-6219
Jun 18, 2019
Organic Conceptions and Proov Form Strategic Alliance that Brings Hope to Couples Struggling with Infertility
Jun 13, 2019
Contraceptives Market to Expand at a Healthy CAGR of 6.10%; Easy Availability of Contraceptive Devices to Propel Demand - TMR
Jun 06, 2019
Exeltis USA, Inc. Announces the Approval of Slynd(TM), the First and Only Progestin-Only Pill Providing Pregnancy Prevention with a 24/4 Dosing Regimen and 24-hour Missed Pill Window
Mar 29, 2019
Pharmascience Inc. launches (Pr)pms-PROGESTERONE 200 mg capsule indicated as an adjunct to postmenopausal estrogen replacement therapy
Mar 25, 2019
Slayback Pharma announces approval of Hydroxyprogesterone Caproate Injection, USP 250 mg/ 1 mL in a single-dose vial, generic equivalent of Makena® Injection 250 mg/ 1 mL
Mar 14, 2019
Contraceptives: Opportunity Analysis and Forecasts to 2027
Mar 07, 2019
Forendo Pharma Successfully Completes Phase 1a Clinical Trial of FOR-6219 for the Treatment of Endometriosis
Mar 05, 2019
Enteris BioPharma Supports Endometriosis Awareness Month